Chlorine in PDB 4gql: Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1
Enzymatic activity of Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1
All present enzymatic activity of Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1:
3.4.24.65;
Protein crystallography data
The structure of Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1, PDB code: 4gql
was solved by
E.A.Stura,
L.Vera,
F.Beau,
L.Devel,
E.Cassar-Lajeunesse,
V.Dive,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
32.60 /
1.15
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
69.580,
63.390,
36.900,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
13.3 /
15.4
|
Other elements in 4gql:
The structure of Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1 also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1
(pdb code 4gql). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the
Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1, PDB code: 4gql:
Jump to Chlorine binding site number:
1;
2;
Chlorine binding site 1 out
of 2 in 4gql
Go back to
Chlorine Binding Sites List in 4gql
Chlorine binding site 1 out
of 2 in the Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl306
b:16.2
occ:0.58
|
CL1
|
A:R47306
|
0.0
|
16.2
|
0.6
|
H3
|
A:R47306
|
0.5
|
23.6
|
0.4
|
C4
|
A:R47306
|
1.5
|
19.6
|
0.4
|
C1
|
A:R47306
|
1.7
|
18.2
|
0.6
|
C3
|
A:R47306
|
2.5
|
17.9
|
0.4
|
C5
|
A:R47306
|
2.5
|
18.5
|
0.4
|
C3
|
A:R47306
|
2.6
|
17.3
|
0.6
|
C2
|
A:R47306
|
2.6
|
18.6
|
0.6
|
H1
|
A:R47306
|
2.6
|
22.3
|
0.6
|
H2
|
A:R47306
|
2.6
|
21.5
|
0.4
|
O
|
A:PRO232
|
2.7
|
22.9
|
1.0
|
H4
|
A:R47306
|
2.7
|
22.2
|
0.4
|
H2
|
A:R47306
|
2.7
|
20.8
|
0.6
|
HA
|
A:LYS233
|
2.8
|
23.4
|
0.3
|
HE2
|
A:LYS241
|
2.9
|
28.8
|
0.8
|
HA
|
A:LYS233
|
3.0
|
22.6
|
0.7
|
HZ1
|
A:LYS241
|
3.3
|
34.9
|
0.8
|
O
|
A:HOH594
|
3.4
|
37.0
|
1.0
|
C
|
A:PRO232
|
3.5
|
19.6
|
1.0
|
HE3
|
A:LYS241
|
3.5
|
29.6
|
0.2
|
O
|
A:ALA234
|
3.5
|
12.4
|
1.0
|
CA
|
A:LYS233
|
3.5
|
19.5
|
0.3
|
HB3
|
A:PHE237
|
3.6
|
13.0
|
1.0
|
CA
|
A:LYS233
|
3.6
|
18.8
|
0.7
|
CE
|
A:LYS241
|
3.6
|
24.0
|
0.8
|
C
|
A:LYS233
|
3.6
|
17.5
|
1.0
|
C1
|
A:R47306
|
3.7
|
17.0
|
0.4
|
NZ
|
A:LYS241
|
3.7
|
29.0
|
0.8
|
HZ3
|
A:LYS241
|
3.7
|
34.9
|
0.8
|
HD2
|
A:LYS241
|
3.8
|
27.7
|
0.2
|
C6
|
A:R47306
|
3.9
|
15.4
|
0.6
|
C6
|
A:R47306
|
3.9
|
15.3
|
0.4
|
HB2
|
A:PHE237
|
3.9
|
13.0
|
1.0
|
N
|
A:LYS233
|
3.9
|
18.7
|
1.0
|
N
|
A:ALA234
|
3.9
|
15.1
|
1.0
|
C4
|
A:R47306
|
3.9
|
16.2
|
0.6
|
HE3
|
A:LYS241
|
4.0
|
28.8
|
0.8
|
H
|
A:ALA234
|
4.0
|
18.1
|
1.0
|
O
|
A:LYS233
|
4.1
|
18.4
|
1.0
|
CB
|
A:PHE237
|
4.1
|
10.8
|
1.0
|
HB3
|
A:LYS241
|
4.2
|
22.5
|
0.2
|
C
|
A:ALA234
|
4.2
|
12.4
|
1.0
|
CE
|
A:LYS241
|
4.3
|
24.7
|
0.2
|
HB3
|
A:LYS241
|
4.3
|
24.0
|
0.8
|
O
|
A:HOH641
|
4.3
|
44.6
|
1.0
|
C2
|
A:R47306
|
4.3
|
14.9
|
0.4
|
HA
|
A:PRO232
|
4.4
|
20.6
|
1.0
|
C5
|
A:R47306
|
4.4
|
14.6
|
0.6
|
HE2
|
A:LYS241
|
4.4
|
29.6
|
0.2
|
HD2
|
A:PHE237
|
4.5
|
13.7
|
1.0
|
CD
|
A:LYS241
|
4.5
|
23.1
|
0.2
|
CA
|
A:PRO232
|
4.6
|
17.2
|
1.0
|
HZ2
|
A:LYS241
|
4.6
|
34.9
|
0.8
|
CG
|
A:PHE237
|
4.6
|
10.7
|
1.0
|
HG3
|
A:LYS233
|
4.6
|
31.5
|
0.7
|
H
|
A:LYS233
|
4.7
|
22.4
|
0.7
|
H
|
A:LYS233
|
4.7
|
22.4
|
0.3
|
CA
|
A:ALA234
|
4.7
|
13.3
|
1.0
|
O
|
A:HOH629
|
4.7
|
55.9
|
1.0
|
H3
|
A:R47306
|
4.7
|
19.4
|
0.6
|
H5
|
A:R47306
|
4.7
|
15.0
|
0.4
|
HB2
|
A:LYS241
|
4.7
|
24.0
|
0.8
|
HA
|
A:VAL235
|
4.7
|
13.0
|
1.0
|
CD2
|
A:PHE237
|
4.8
|
11.4
|
1.0
|
HG2
|
A:LYS233
|
4.8
|
30.4
|
0.3
|
HB2
|
A:LYS241
|
4.8
|
22.5
|
0.2
|
H5
|
A:R47306
|
4.8
|
15.2
|
0.6
|
CL1
|
A:R47306
|
4.8
|
20.3
|
0.4
|
CB
|
A:LYS233
|
4.9
|
21.7
|
0.3
|
HD3
|
A:LYS241
|
4.9
|
32.8
|
0.8
|
CD
|
A:LYS241
|
4.9
|
27.4
|
0.8
|
O
|
A:HOH555
|
4.9
|
21.4
|
1.0
|
CB
|
A:LYS241
|
4.9
|
18.8
|
0.2
|
CB
|
A:LYS241
|
4.9
|
20.0
|
0.8
|
O
|
A:ASP231
|
4.9
|
16.4
|
1.0
|
H
|
A:PHE237
|
5.0
|
12.5
|
1.0
|
CB
|
A:LYS233
|
5.0
|
22.4
|
0.7
|
|
Chlorine binding site 2 out
of 2 in 4gql
Go back to
Chlorine Binding Sites List in 4gql
Chlorine binding site 2 out
of 2 in the Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of the Catalytic Domain of Human MMP12 in Complex with Selective Phosphinic Inhibitor RXP470.1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl306
b:20.3
occ:0.42
|
CL1
|
A:R47306
|
0.0
|
20.3
|
0.4
|
H3
|
A:R47306
|
0.8
|
19.4
|
0.6
|
C4
|
A:R47306
|
1.6
|
16.2
|
0.6
|
C1
|
A:R47306
|
1.7
|
17.0
|
0.4
|
O
|
A:HOH609
|
1.8
|
25.7
|
0.9
|
H2
|
A:R47306
|
2.2
|
20.8
|
0.6
|
C3
|
A:R47306
|
2.3
|
17.3
|
0.6
|
H2
|
A:R47306
|
2.3
|
21.5
|
0.4
|
C3
|
A:R47306
|
2.4
|
17.9
|
0.4
|
HG21
|
A:VAL243
|
2.7
|
23.0
|
1.0
|
HE1
|
A:PHE248
|
2.7
|
15.8
|
1.0
|
C5
|
A:R47306
|
2.8
|
14.6
|
0.6
|
C2
|
A:R47306
|
2.8
|
14.9
|
0.4
|
H4
|
A:R47306
|
3.0
|
17.5
|
0.6
|
H1
|
A:R47306
|
3.1
|
17.9
|
0.4
|
HG11
|
A:VAL243
|
3.1
|
24.4
|
1.0
|
HD1
|
A:PHE248
|
3.3
|
16.3
|
1.0
|
O
|
A:HOH629
|
3.4
|
55.9
|
1.0
|
HG22
|
A:VAL243
|
3.4
|
23.0
|
1.0
|
CG2
|
A:VAL243
|
3.4
|
19.2
|
1.0
|
O
|
A:HOH431
|
3.4
|
24.4
|
1.0
|
CE1
|
A:PHE248
|
3.4
|
13.2
|
1.0
|
C1
|
A:R47306
|
3.5
|
18.2
|
0.6
|
HG13
|
A:VAL243
|
3.8
|
24.4
|
1.0
|
CD1
|
A:PHE248
|
3.8
|
13.6
|
1.0
|
CG1
|
A:VAL243
|
3.8
|
20.3
|
1.0
|
C4
|
A:R47306
|
3.8
|
19.6
|
0.4
|
C6
|
A:R47306
|
4.0
|
15.3
|
0.4
|
C6
|
A:R47306
|
4.0
|
15.4
|
0.6
|
HA
|
A:VAL235
|
4.0
|
13.0
|
1.0
|
HG23
|
A:VAL243
|
4.1
|
23.0
|
1.0
|
HD22
|
A:LEU214
|
4.1
|
14.7
|
1.0
|
HB
|
A:VAL235
|
4.2
|
12.8
|
1.0
|
CB
|
A:VAL243
|
4.2
|
17.6
|
1.0
|
HG23
|
A:VAL235
|
4.2
|
12.5
|
1.0
|
O
|
A:LYS233
|
4.3
|
18.4
|
1.0
|
O
|
A:HOH526
|
4.3
|
21.1
|
1.0
|
C2
|
A:R47306
|
4.3
|
18.6
|
0.6
|
C5
|
A:R47306
|
4.4
|
18.5
|
0.4
|
H3
|
A:R47306
|
4.5
|
23.6
|
0.4
|
HB
|
A:VAL243
|
4.5
|
21.1
|
1.0
|
HG12
|
A:VAL243
|
4.6
|
24.4
|
1.0
|
CZ
|
A:PHE248
|
4.6
|
12.0
|
1.0
|
CA
|
A:VAL235
|
4.7
|
10.8
|
1.0
|
N
|
A:VAL235
|
4.8
|
10.4
|
1.0
|
CB
|
A:VAL235
|
4.8
|
10.6
|
1.0
|
CL1
|
A:R47306
|
4.8
|
16.2
|
0.6
|
HZ
|
A:PHE248
|
4.8
|
14.4
|
1.0
|
HD21
|
A:LEU214
|
4.9
|
14.7
|
1.0
|
O
|
A:ARG249
|
4.9
|
12.7
|
0.6
|
CD2
|
A:LEU214
|
4.9
|
12.2
|
1.0
|
H
|
A:VAL235
|
4.9
|
12.5
|
1.0
|
CG2
|
A:VAL235
|
5.0
|
10.4
|
1.0
|
|
Reference:
B.Czarny,
E.A.Stura,
L.Devel,
L.Vera,
E.Cassar-Lajeunesse,
F.Beau,
V.Calderone,
M.Fragai,
C.Luchinat,
V.Dive.
Molecular Determinants of A Selective Matrix Metalloprotease-12 Inhibitor: Insights From Crystallography and Thermodynamic Studies. J.Med.Chem. V. 56 1149 2013.
ISSN: ISSN 0022-2623
PubMed: 23343195
DOI: 10.1021/JM301574D
Page generated: Sun Jul 21 14:56:20 2024
|